Protonix 20 mg Delayed Release Oral Tablet
RxNorm 352125
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 352125 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Protonix 20 mg Delayed Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Pantoprazole 20 mg Delayed Release Oral Tablet [Protonix]
(Atom ID: 6337772)
PSNPrescribable
Prescribable Name (PSN):
Protonix 20 mg Delayed Release Oral Tablet
(Atom ID: 6361448)
SYPrescribable
Synonym (SY):
Protonix 20 mg Delayed Release Oral Tablet
(Atom ID: 6338076)
SYPrescribable
Synonym (SY):
Protonx 20 mg (pantoprazole sodium sesquihydrate 22.56 mg) Delayed Release Oral Tablet
(Atom ID: 6338075)
Patient Education
Pantoprazole
Pantoprazole is used to treat damage from gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and possible injury of the esophagus (the tube between the throat and stomach) in adults and children 5 years of age and older. Pantoprazole is used to allow the esophagus to heal and prevent further damage to the esophagus in adults with GERD. It is also used to treat conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome in adults. Pantoprazole is in a class of medications called proton-pump inhibitors. It works by decreasing the amount of acid made in the stomach.
[Learn More]
* Please review the disclaimer below.